Skip to main content
. 2016 Nov 23;7(52):87180–87193. doi: 10.18632/oncotarget.13517

Table 8. The associations between rs4149963 and clinical characteristics of hepatocellular carcinoma patients.

Variables AA AG/GG OR(95%CI)a OR(95%CI)b
tumor size
 ≥5cm 218(88.62) 28(11.38) 1.000 1.000
 <5cm 669(89.91) 75(10.08) 1.146(0.723∼1.815) 1.648(0.775∼3.508)
tumor number
 solitary 780(89.34) 93(10.65) 1.000 1.000
 multiple 104(88.89) 13(11.11) 1.048(0.567∼1.940) 1.610(0.614∼4.220)
TNM staging
 T1+T2 738(88.17) 99(11.83) 1.000 1.000
 T3+T4 131(87.33) 19(2.67) 1.081(0.640∼1.828) 0.586(0.189∼1.814)
Combined with liver cirrhosis
 Yes 360(86.96) 51(13.04) 1.000 1.000
 No 516(90.05) 57(9.95) 0.780(0.522∼1.164) 0.759(0.378∼1.527)
AFP level (ng/ml)
 ≥400 603(86.64) 93(13.36) 1.000 1.000
 <400 252(85.71) 42(14.29) 1.081(0.730∼1.601) 0.420(0.168∼1.049)
tumor metastasis
 Yes 117(88.64) 15(11.36) 1.000 1.000
 No 762(88.81) 96(11.19) 1.018(0.571∼1.814) 1.308(0.506∼3.382)

a: OR (95% CI) not adjusted; b: OR (95% CI) adjusted for age, gender, nations, smoking, alcohol consumption, HBV infection, and HCC family history.